Does MYCOPHENOLATE Cause Focal segmental glomerulosclerosis? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Focal segmental glomerulosclerosis have been filed in association with MYCOPHENOLATE (mycophenolic acid). This represents 0.2% of all adverse event reports for MYCOPHENOLATE.
12
Reports of Focal segmental glomerulosclerosis with MYCOPHENOLATE
0.2%
of all MYCOPHENOLATE reports
1
Deaths
11
Hospitalizations
How Dangerous Is Focal segmental glomerulosclerosis From MYCOPHENOLATE?
Of the 12 reports, 1 (8.3%) resulted in death, 11 (91.7%) required hospitalization, and 1 (8.3%) were considered life-threatening.
Is Focal segmental glomerulosclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MYCOPHENOLATE. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does MYCOPHENOLATE Cause?
Diarrhoea (622)
Death (615)
Off label use (572)
Drug ineffective (380)
Pyrexia (374)
Blood creatinine increased (305)
Malaise (288)
Hypertension (280)
Haemoglobin decreased (272)
Product use in unapproved indication (272)
What Other Drugs Cause Focal segmental glomerulosclerosis?
TACROLIMUS (339)
MYCOPHENOLATE MOFETIL (181)
PREDNISONE (173)
CYCLOSPORINE (96)
METHYLPREDNISOLONE (81)
PREDNISOLONE (73)
RITUXIMAB (73)
BASILIXIMAB (67)
OMEPRAZOLE (60)
LANSOPRAZOLE (55)
Which MYCOPHENOLATE Alternatives Have Lower Focal segmental glomerulosclerosis Risk?
MYCOPHENOLATE vs MYCOPHENOLATE MOFETIL
MYCOPHENOLATE vs MYCOPHENOLATE MOFETIL\MYCOPHENOLATE MOFETIL
MYCOPHENOLATE vs MYCOPHENOLIC ACID
MYCOPHENOLATE vs MYFORTIC
MYCOPHENOLATE vs MYRBETRIQ